Ferguson Joe W. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Apr 29, 2021
Insider Transaction Report
Form 4
Ferguson Joe W.
SVP, Research & Development
Transactions
- Other
Series A Preferred Stock
2021-04-27+1,981→ 85,575 total(indirect: By Trust)→ Common Stock (1,981 underlying) - Conversion
Common Stock
2021-04-27+85,575→ 85,575 total(indirect: By Trust) - Conversion
Series A Preferred Stock
2021-04-27−85,575→ 0 total(indirect: By Trust)→ Common Stock (85,575 underlying)
Holdings
- 111,115
Common Stock
Footnotes (2)
- [F1]Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.